Lysosomal storage diseases: Natural history and ethical and economic aspects
- 1 July 2006
- journal article
- review article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 88 (3) , 208-215
- https://doi.org/10.1016/j.ymgme.2006.01.010
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Paediatric non-neuronopathic Gaucher disease: recommendations for treatment and monitoringEuropean Journal of Pediatrics, 2004
- Comparative Efficacy of Dose Regimens in Enzyme Replacement Therapy of Type I Gaucher DiseaseBlood Cells, Molecules, and Diseases, 2000
- Gaucher DiseaseMedicine, 1995
- Treatment regimens in Gaucher's diseaseThe Lancet, 1995
- Gaucher disease as a paradigm of current issues regarding single gene mutations of humans.Proceedings of the National Academy of Sciences, 1993
- Treatment of Gaucher's DiseaseNew England Journal of Medicine, 1993
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease.Proceedings of the National Academy of Sciences, 1990
- Human β-glucuronidase: In vivo clearance and in vitro uptake by a glycoprotein recognition system on reticuloendothelial cellsCell, 1978
- TREATMENT OF GAUCHER'S DISEASE WITH LIPOSOME-ENTRAPPED GLUCOCEREBROSIDE: β-GLUCOSIDASEThe Lancet, 1977